Research suggests that ashwagandha may help reduce perceived stress, with one 8-week randomized, double-blind, placebo-controlled trial finding that an aqueous root and leaf extract reduced self-reported chronic stress across multiple doses, with effects attributed to modulation of the hypothalamic-pituitary-adrenal axis. A metabolomic profiling study supports a plausible mechanistic basis for these effects, indicating that ashwagandha's therapeutic properties likely arise from the synergistic action of a broad range of bioactive compounds including withanolides, alkaloids, and phenolics rather than any single ingredient. However, the evidence is not uniformly positive — a 2026 safety review and a published case report both highlight potential concerns including gastrointestinal effects, drug interactions, and rare but serious liver injury, with the case report documenting drug-induced liver injury in a person who used ashwagandha specifically for stress relief over several months. Studies indicate that while short-term use in healthy adults appears generally tolerable, the current body of evidence is limited in scope, and researchers have called for larger long-term trials, standardized dosing protocols, and clearer regulatory guidance before firm conclusions about both efficacy and safety can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Effects of Withania somnifera Extract in Chronically Stressed Adults: A Rando... | RCT | 2024 | Supports | 100 |
| Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical an... | Review | 2026 | Mixed | 95 |
| [A case where phenobarbital was remarkably effective against drug-induced liv... | Other | 2026 | Mixed | 90 |
| Metabolomic Profiling of Ashwagandha ( <i>Withania somnifera</i> ): Linking B... | Other | 2025 | Supports | 85 |